Learn more about Penn CVI Symposium on Translational Science and Emerging Therapy for Heart Failure
The Symposium on Translational Science and Emerging Therapy for Heart Failure will be held at the Smilow Center for Translational Research in the Arthur H. Rubenstein Auditorium and Lobby
Research and Clinical Trials at the Penn Cardiovascular Institute
The Penn Cardiovascular Institute (CVI) is a multi-disciplinary group of researchers and physicians dedicated to scientific discoveries and medical breakthroughs in heart and vascular care. Penn CVI focuses on translational research, which means taking basic research on the heart and using it to develop new clinical devices and treatments for cardiovascular disease.
Learn more about the Penn Cardiovascular Institute
Research Interests
Principal Investigators
Penn CVI's principal investigators work to translate basic discoveries into novel prevention strategies, diagnostic modalities and treatments for cardiovascular disease.
Browse Principal Investigators
Search Clinical Trials
Penn CVI coordinates cardiovascular clinical trials and research to bring life-saving procedures, devices and medications to the public.